Results 211 to 218 of about 49,566 (218)

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

The Lancet Gastroenterology and Hepatology, 2016
Scott Fung, Wan-Long Chuang, Edward Gane
exaly  

HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B

Hepatology, 2008
Michael W Fried, George Lau, Y-F Liaw
exaly  

PREVENTION OF THE HBsAg CARRIER STATE IN NEWBORN INFANTS OF MOTHERS WHO ARE CHRONIC CARRIERS OF HBsAg AND HBeAg BY ADMINISTRATION OF HEPATITIS-B VACCINE AND HEPATITIS-B IMMUNOGLOBULIN

Lancet, The, 1984
exaly  

HBeAg vetting of UK medical student applicants

Lancet, The, 1994
exaly  

RELATIONSHIP BETWEEN CARRIAGE OF HBeAg AND HBsAg

Lancet, The, 1983
exaly  

HBeAg/ANTI-HBe AND ALPHA-FETOPROTEIN LEVELS IN PRIMARY HEPATOCELLULAR CARCINOMA

Lancet, The, 1982
exaly  

MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION

Lancet, The, 1989
exaly  

The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis B

Journal of Hepatology, 2001
exaly